|
Volumn 90, Issue 10, 2010, Pages 1050-1051
|
Subcutaneous pig islet xenografts: Getting under your skin to cure diabetes?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALGINIC ACID;
COLLAGEN;
CYTOKINE;
POLYMER;
REACTIVE OXYGEN METABOLITE;
ADAPTIVE IMMUNITY;
CYTOKINE RELEASE;
DEVICE;
DIABETES MELLITUS;
DNA MODIFICATION;
GLYCEMIC CONTROL;
GRAFT DYSFUNCTION;
GRAFT FAILURE;
GRAFT RECIPIENT;
GRAFT SURVIVAL;
HUMAN;
HUMORAL IMMUNITY;
HYPERGLYCEMIA;
HYPOXIA;
IMMUNOCOMPETENT CELL;
IMMUNOGENICITY;
IMMUNOSUPPRESSIVE TREATMENT;
INNATE IMMUNITY;
MICROENCAPSULATION;
MONOLAYER CELLULAR DEVICE;
NONHUMAN;
NOTE;
ORGAN DONOR;
OXIDATIVE STRESS;
PANCREAS ISLET;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
PROTEIN SECRETION;
RETRANSPLANTATION;
SUBCUTANEOUS TISSUE;
SWINE;
TREATMENT OUTCOME;
XENOGRAFT;
XENOTRANSPLANTATION;
ANIMALS;
DIABETES MELLITUS;
HUMANS;
ISLETS OF LANGERHANS TRANSPLANTATION;
MODELS, ANIMAL;
PRIMATES;
SUBCUTANEOUS TISSUE;
SWINE;
TRANSPLANTATION, HETEROLOGOUS;
|
EID: 78650292840
PISSN: 00411337
EISSN: None
Source Type: Journal
DOI: 10.1097/TP.0b013e3181f6e286 Document Type: Note |
Times cited : (5)
|
References (6)
|